Full Name
Wai Meng David Tai
 
 
Email
gmstwmd@nus.edu.sg
 

Publications

Refined By:
Policy:  Open

Results 1-4 of 4 (Search time: 0.004 seconds).

Issue DateTitleAuthor(s)
11-Mar-2022A phase 1 study of the safety, pharmacokinetics and pharmacodynamics of escalating doses followed by dose expansion of the selective inhibitor of nuclear export (SINE) selinexor in Asian patients with advanced or metastatic malignanciesHo, Jingshan ; Heong, Valerie; Yong, Wei Peng ; Soo, Ross ; Chee, Cheng Ean ; Wong, Andrea ; Sundar, Raghav; Thian, Yee Liang ; Gopinathan, Anil ; Pang, Mei Yan; Koe, Priscillia; Jeraj, Santhiay Nathan; Soe, Phyu Pyar; Soe, Mu Yar; Tang, Tiffany ; Ng, Matthew CH; Tai, David WM ; Tan, Tira JY ; Xu, Hongmei; Chang, Hua; Landesman, Yosef; Shah, Jatin ; Shacham, Sharon; Lee, Soo Chin ; Tan, Daniel SW ; Goh, Boon Cher ; Tan, David SP 
223-Aug-2022First-line Systemic Therapies for Advanced Hepatocellular Carcinoma: A Systematic Review and Patient-Level Network Meta-AnalysisFong K.Y. ; Zhao J.J.; Sultana R. ; Lee J.J.X. ; Lee S.Y.; Chan S.L.; Yau T.; Tai D.W.M. ; Sundar R. ; Too C.W. 
326-Oct-2021Impact of Immune-Related Adverse Events on Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular CarcinomaNg K.Y.Y.; Tan S.H. ; Tan J.J.E.; Tay D.S.H.; Lee A.W.X.; Ang A.J.S.; Wong L.W.J.; Choo S.P.; Tai D.W.-M. ; Lee J.J.X. 
41-Aug-2022Trials without borders—decentralized trials and ensuring access to novel cancer therapies during a global pandemicTan, AC ; Tan, TJY; Saw, SPL ; Lam, JYC ; Yap, YS ; Lim, WT ; Tai, DWM ; Ng, MCH ; Tan, DSW